The invention belongs to the field of traditional Chinese medicines, and particularly relates to a
traditional Chinese medicine composition for treating colon
cancer. The traditional Chinese medicinecomprises the following main active ingredients in parts by weight: 2-4 parts of radix astragali, 0.5-1 part of herba epimedii, 1-1.5 parts of radix paeoniae rubra, 0.5-1 part of rhizoma curcumae, 1.5-3 parts of rhizoma smilacis glabrae and 0.5-1.5 parts of fried rhizoma atractylodis macrocephalae. The invention further provides a preparation method and application of the
traditional Chinese medicine composition for treating colon
cancer. Experiments of
colon cancer tumor-bearing mice show that when the
traditional Chinese medicine composition for treating colon
cancer is combined with chemotherapeutics for application, although the
tumor inhibition effect of the chemotherapeutics is not obviously enhanced, the survival time of the mice can be obviously prolonged, the
weight loss caused bythe chemotherapeutics is relieved, the
T lymphocyte level of the mice is improved, particularly, the levels of CD4 <+> T lymphocytes and CD8 <+> T lymphocytes are remarkably improved, indicating thatthe traditional Chinese
medicine composition for treating the colon cancer can improve the body
immunity of a patient suffering from the colon cancer, the living quality of the patient is improved, and the survival time of the patient is prolonged.